Potential Host Range of Multiple SARS-like Coronaviruses and an Improved ACE2-Fc Variant That Is Potent Against Both SARS-CoV-2 and SARS-CoV-1

doi 10.1101/2020.04.10.032342
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

SARS-COV-2 and Infectivity

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Human ACE2 Receptor Polymorphisms Predict SARS-CoV-2 Susceptibility

2020English

Authors’ Response: Plenty of Coronaviruses but No SARS-CoV-2

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2020English

ACE2 Fragment as a Decoy for Novel SARS-Cov-2 Virus

2020English

Potent Human Monoclonal Antibodies Against SARS CoV, Nipah and Hendra Viruses

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2009English

On the Interactions of the Receptor-Binding Domain of SARS-CoV-1 and SARS-CoV-2 Spike Proteins With Monoclonal Antibodies and the Receptor ACE2

2020English

Composition and Divergence of Coronavirus Spike Proteins and Host ACE2 Receptors Predict Potential Intermediate Hosts of SARS-CoV-2

Journal of Medical Virology
VirologyInfectious Diseases
2020English

SARS-CoV-2 Infection of Kidney Organoids Prevented With Soluble Human ACE2

Nature Reviews Nephrology
Nephrology
2020English

SARS-CoV-2 Prion-Like Domains in Spike Proteins Enables Higher Affinity to ACE2

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy